PL363117A1 - Koniugaty GCSF - Google Patents

Koniugaty GCSF

Info

Publication number
PL363117A1
PL363117A1 PL00363117A PL36311700A PL363117A1 PL 363117 A1 PL363117 A1 PL 363117A1 PL 00363117 A PL00363117 A PL 00363117A PL 36311700 A PL36311700 A PL 36311700A PL 363117 A1 PL363117 A1 PL 363117A1
Authority
PL
Poland
Prior art keywords
conjugates
gcsf
gcsf conjugates
mixture
formula
Prior art date
Application number
PL00363117A
Other languages
English (en)
Other versions
PL203462B1 (pl
Inventor
Pascal Sebastian Bailon
Original Assignee
Hoffmann-La Roche Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann-La Roche Inc. filed Critical Hoffmann-La Roche Inc.
Publication of PL363117A1 publication Critical patent/PL363117A1/pl
Publication of PL203462B1 publication Critical patent/PL203462B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polyethers (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
PL363117A 1999-01-29 2000-01-19 Fizjologicznie aktywne koniugaty czynnika stymuluj acego tworzenie kolonii granulocytów (GCSF), zawieraj ace je kompozycje i sposób wytwarzania koniugatu PEG-GCSF PL203462B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11791799P 1999-01-29 1999-01-29
US60/117,917 1999-01-29

Publications (2)

Publication Number Publication Date
PL363117A1 true PL363117A1 (pl) 2004-11-15
PL203462B1 PL203462B1 (pl) 2009-10-30

Family

ID=

Also Published As

Publication number Publication date
CA2361766A1 (en) 2000-08-03
DE60004172T2 (de) 2004-04-22
NO20013700D0 (no) 2001-07-27
US20070219356A1 (en) 2007-09-20
US20080287659A1 (en) 2008-11-20
SK286898B6 (sk) 2009-07-06
EA004685B1 (ru) 2004-06-24
ES2204509T3 (es) 2004-05-01
IL144361A0 (en) 2002-05-23
EA200400067A1 (ru) 2004-04-29
HU228488B1 (en) 2013-03-28
YU54301A (sh) 2003-10-31
ZA200105932B (en) 2002-10-18
US20050196378A1 (en) 2005-09-08
EP1157037B1 (en) 2003-07-30
US20030130193A1 (en) 2003-07-10
JP2002540065A (ja) 2002-11-26
EP1157037A1 (en) 2001-11-28
NO20013700L (no) 2001-09-25
PT1157037E (pt) 2003-12-31
DK1157037T3 (da) 2003-11-24
CN1376164A (zh) 2002-10-23
HK1049673A1 (zh) 2003-05-23
CZ300546B6 (cs) 2009-06-10
BG65213B1 (bg) 2007-07-31
CA2361766C (en) 2011-12-06
RS50928B (sr) 2010-08-31
NZ513113A (en) 2004-03-26
HUP0203652A3 (en) 2005-01-28
DE60004172D1 (de) 2003-09-04
KR20020007296A (ko) 2002-01-26
NO331787B1 (no) 2012-04-02
HUP0203652A2 (hu) 2003-03-28
AU2618500A (en) 2000-08-18
EA200100838A1 (ru) 2002-04-25
SK10352001A3 (sk) 2002-06-04
CZ20012654A3 (cs) 2002-05-15
BR0007781A (pt) 2002-02-05
MXPA01007609A (es) 2003-06-24
ATE246202T1 (de) 2003-08-15
WO2000044785A1 (en) 2000-08-03
BG105851A (en) 2002-06-28
KR100689212B1 (ko) 2007-03-09

Similar Documents

Publication Publication Date Title
IL144361A0 (en) Gcsf conjugates
PL366198A1 (pl) Nowe związki
IL150986A0 (en) 1,2,3,4,- tetrahydroisoquinoline derivatives
AU2002210993A1 (en) Medicinal compositions for concominant use as anticancer agents
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
MY127144A (en) New anticholinergics which may be used as medicaments as well as processes for preparing them
HRP20031003A2 (en) 4'-substituted nukleosides
AU7315301A (en) Compounds and compositions for delivering active agents
MXPA03004780A (es) Nuevas sulfamidas.
MY122391A (en) Piperazine derivatives as 5-ht1b antagonists
HUP0303069A3 (en) Imidazole derivatives, pharmaceutical compositions containing them and their use
AU2002212894A1 (en) N-type calcium channel antagonists for the treatment of pain
GEP20063972B (en) Streptogramin derivatives, preparation and compositions containing them
YU59400A (sh) Azabiciklični ligandi 5ht1 receptora
ATE268175T1 (de) Decursin-enthaltende pharmazeutische zusammensetzungen
ZA991546B (en) Streptogramin derivatives, their preparation and compositions containing them.
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
EP1092431A3 (en) Lasofoxifene compositions
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
IL148161A0 (en) Process for the preparation of 2-cyanopyridines
MXPA03010259A (es) Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos.
YU5302A (sh) Derivati streptogramina, njihovo dobivanje i smeše koje ih sadrže
AU7655600A (en) 1,4-dioxacycloalkane-2-one and 1,4-dioxacycloalkene-2-one
YU23498A (sh) Herbicidni 3,5-difluoropiridini
AU4127300A (en) Use of cellulose microfibrils in fermented milk compositions